Healthcare AstraZeneca Buys Fusion Pharma for Up to $2.4BAfter a shift in focus to develop Covid-19 vaccines, the Fusion deal marks a return to CEO Pascal Soriot’s focus on oncology. March 19, 2024
Healthcare AstraZeneca Buys Cancer Drug Developer Gracell for Up to $1.2 BillionThe acquisition will enrich Astra’s pipeline with a so-called CAR-T therapy that modifies a patient’s own immune cells to fight cancer. December 26, 2023
Healthcare Astra Strikes $1B Pfizer Deal, Dismisses Trial ConcernsThe deal builds on Astra’s investment in its rare disease business since purchasing Alexion for $39 billion in 2021. July 28, 2023
Strategic Buyers AstraZeneca Buys CinCor Pharma for Up to $1.8BThe deal is the first sizable one for Astra since the $39 billion takeover of rare-disease specialist Alexion Pharmaceuticals Inc. in 2021. January 9, 2023
Healthcare AstraZeneca Makes Rare Disease PushAcquiring Alexion would bolster AstraZeneca in areas such as the treatment of blood disorders. December 14, 2020